Literature DB >> 6992276

Survival of Escherichia coli host-vector systems in the mammalian intestine.

S B Levy, B Marshall, D Rowse-Eagle, A Onderdonk.   

Abstract

Survival in the mouse and human intestine of Escherichia coli host-vector systems used and proposed for recombinant DNA technology was assessed. There was no detectable survival of severely disabled E. coli K12 strain X1776 in mice or in human subjects 24 hours after ingestion. The same strain bearing the plasmid pBR322, however, was recovered from human subjects for 4 days in amounts of six organisms for every million ingested. Nondisabled E. coli K12 strain X1666, with or without pBR322, survived in 10(4)-fold greater numbers and for 2 days longer, with better recovery of the plasmid-containing derivative. Although the plasmid-bearing strains were recovered for longer periods, no intestinal colonization was noted. Despite the presence of pBR322 for a maximum of 6 days in the human intestine, there was no evidence that it was transferred from either bacterial host to endogenous aerobic fecal bacteria.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6992276     DOI: 10.1126/science.6992276

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  10 in total

Review 1.  Relationship between safety data and biocontainment design in the environmental assessment of fermentation organisms--an FDA perspective.

Authors:  R A Jones; J C Matheson
Journal:  J Ind Microbiol       Date:  1993-07

2.  Fate in sewage of a recombinant Escherichia coli K-12 strain used in the commercial production of bovine somatotropin.

Authors:  M A Heitkamp; J F Kane; P J Morris; M Bianchini; M D Hale; G Bogosian
Journal:  J Ind Microbiol       Date:  1993-07

3.  The amino-terminal functions of the simian virus 40 large T antigen are required to overcome wild-type p53-mediated growth arrest of cells.

Authors:  R S Quartin; C N Cole; J M Pipas; A J Levine
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

4.  High frequency of antimicrobial resistance in human fecal flora.

Authors:  S B Levy; B Marshall; S Schluederberg; D Rowse; J Davis
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

5.  Absence of persistence and transfer of genetic material by recombinant Escherichia coli in conventional, antibiotic-treated mice.

Authors:  R J Yancey; S F Kotarski; K K Thurn; R A Lepley; J E Mott
Journal:  J Ind Microbiol       Date:  1993-07

6.  Studies with enteroaggregative Escherichia coli in the gnotobiotic piglet gastroenteritis model.

Authors:  S Tzipori; J Montanaro; R M Robins-Browne; P Vial; R Gibson; M M Levine
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

7.  Escherichia coli K12 does not colonize the gastrointestinal tract of Fischer-344 rats.

Authors:  W L Muth; F T Counter; K K Richardson; L F Fisher
Journal:  J Ind Microbiol       Date:  1993-07

8.  Experimental and mathematical models of Escherichia coli plasmid transfer in vitro and in vivo.

Authors:  R Freter; R R Freter; H Brickner
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

9.  Fate in water of a recombinant Escherichia coli K-12 strain used in the commercial production of bovine somatotropin.

Authors:  G Bogosian; P J Morris; M D Hale; J F Kane
Journal:  J Ind Microbiol       Date:  1992-01

10.  Relative colonizing abilities of human fecal and K 12 strains of Escherichia coli in the large intestines of streptomycin-treated mice.

Authors:  M L Myhal; D C Laux; P S Cohen
Journal:  Eur J Clin Microbiol       Date:  1982-06       Impact factor: 3.267

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.